Sign In
Buy ATC
$21.25
-0.312 (-1.45%)
At Close: Jul 24, 2026
How Atotech (ATC) Stock Stands Out in a Strong Industry
12:31pm, Tuesday, 07'th Sep 2021
Atotech (ATC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Atotech Limited (ATC) CEO Geoff Wild on Q2 2021 Results - Earnings Call Transcript
02:50pm, Wednesday, 11'th Aug 2021
Atotech Limited (ATC) CEO Geoff Wild on Q2 2021 Results - Earnings Call Transcript
Atotech Reports Second Quarter 2021 Results and Raises 2021 Full Year Guidance
06:00am, Wednesday, 11'th Aug 2021
BERLIN, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, today reported record financia
Moore Kuehn Encourages IKNX, ISOS, ATC and JAX Investors to Contact Law Firm
01:35pm, Tuesday, 06'th Jul 2021
NEW YORK, July 6, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning wh
Atotech and Nabet India launch Covid-19 awareness campaign “Atotech Cares”
03:19am, Tuesday, 08'th Jun 2021
BERLIN, June 08, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, is joining together with Natio
Atotech celebrates 25th anniversary of Atotech Korea Ltd.
12:00am, Wednesday, 26'th May 2021
BERLIN, May 26, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, celebrated the 25th anniversary
Atotech Limited (ATC) CEO Geoff Wild on Q1 2021 Results - Earnings Call Transcript
10:15am, Saturday, 08'th May 2021
Atotech Limited (ATC) CEO Geoff Wild on Q1 2021 Results - Earnings Call Transcript
Atotech Reports First Quarter 2021 Results and Raises 2021 Full Year Guidance
06:00am, Tuesday, 04'th May 2021
BERLIN, May 04, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, today reported its financial re
Atotech appoints Sarah Spray as Global Head of Investor Relations & Communications
09:13am, Thursday, 25'th Mar 2021
BERLIN, March 25, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, announced today that Sarah Sp
Atotech Announces Refinancing of Senior Secured Credit Facilities
04:20pm, Thursday, 18'th Mar 2021
BERLIN, March 18, 2021 (GLOBE NEWSWIRE) -- Atotech Limited (NYSE: ATC) (“Atotech” or the “Company”), a leading specialty chemicals technology company and a market leader in advanced electropla
Atotech Reports Fourth Quarter and Full Year 2020 Results and Provides 2021 Full Year Guidance
06:00am, Thursday, 04'th Mar 2021
BERLIN, March 04, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, today reported its financial
Atotech Announces Closing of Its Initial Public Offering
04:15pm, Monday, 08'th Feb 2021
BERLIN, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, closed its initial public offe
U.S. IPO Weekly Recap: Biotechs Flood The IPO Market In A 14 IPO Week
02:14am, Monday, 08'th Feb 2021
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. German chemicals group Atotech downsized and priced below the range to raise $498
Atotech: Interesting, Yet Some Doubts
05:47pm, Friday, 05'th Feb 2021
Atotech is the former surface finishing business of Total, acquired by Carlyle a while ago. The company has gone public, yet investors do not like leverage and relatively modest topline sales growth d
A Busy Day for Biotech IPOs
02:35pm, Thursday, 04'th Feb 2021
Three biotechs—Sana Biotechnology, Landos Biopharma, Sensei Biotherapeutics—and chemicals specialist Atotech made their public-market debut Thursday. Here's how they fared.
